Invitation to Brighter's Q2 2022 Conference Call

Brighter AB (Publ) (”Brighter or the Company”) invites to a conference call following the publication of the Company's Q2 2022 results on August 25.

Following the publication of Brighter’s Q2 2022 interim results, the company will hold a conference call (in Swedish) for shareholders, analysts, and the media on Wednesday August 25, 2022 at 15.00 CET. The call will include a presentation followed by a question and answer session. 

Brighter encourages those who intend to participate in the conference call to send questions in advance to ir@brighter.se.

We look forward to your participation.

Telephone conference in Swedish
To connect, please fill in your details via the registration link below. Once you have registered, you will receive a separate email with dial-in numbers and PIN codes.

Date / time: August 25, 2022, at 15:00 CET
(Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna)

Registration: Click here for registration

For further information, please contact:
Investor Relations
ir@brighter.se

Certified Adviser
Brighter’s Certified Adviser är Mangold Fondkommission AB,
+46 8 5277 5020, ca@mangold.se, www.mangold.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones, and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

For more information, please visit our website at https://brighter.se/.